MXC News: Historic Milestone: UK Patients Receive First CannEpil® Delivery through 'I AM Billy Foundation' - 31st May 2023, 6:04pm

annb0t

Top 20
MGC Pharma's pioneering cannabis-based treatment for refractory epilepsy now available to patients in the United Kingdom

LONDON, May 31, 2023 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a leading European pharmaceutical firm specializing in plant-derived medications, announced today that its ground-breaking Investigational Medicinal Product (IMP), CannEpil®, has been successfully imported and received by its first patients in the United Kingdom. mgcpharm...

>>> Read more: Historic Milestone: UK Patients Receive First CannEpil® Delivery through 'I AM Billy Foundation' and GMC Specialist Register
 
Top Bottom